Abstract Charcot-Marie-Tooth disease type 1B (CMT 1B) is caused by mutations in the gene coding for peripheral myelin protein zero (MPZ, P0) that plays a fundamental role in adhesion and compaction of peripheral myelin. Here we report a Costa Rican family with a hereditary peripheral neuropathy due to a novel Tyr145-Ser MPZ mutation. Four family members were heterozygously affected; two siblings of two heterozygous carriers were homozygous for this mutation. On neurological examination the heterozygous parents and their homozygous children both showed distal sensory deficits. The mother and the siblings displayed impaired deep tendon reflexes and mild sensory ataxia. The homozygous individuals were more severely affected with an earlier age of onset, distal motor weakness, and pupillary abnormalities. Electrophysiological studies revealed both signs of demyelination and axonal nerve degeneration. The sural nerve biopsy of one sibling showed thinly myelinated nerve fibers, onion bulb formation, and clusters of regenerating fibers. On electron microscopy axonal degeneration and decompaction of inner myelin layers were found. This Costa Rican family shows phenotypic variability depending on the homozygous or heterozygous state of the Tyr145Ser mutation carriers.
Introduction
Hereditary motor and sensory neuropathies (HMSN) are a clinically and genetically heterogeneous group of disorders of the peripheral nervous system. The most-common form is HMSN type 1, synonymous to Charcot-MarieTooth (CMT) disease type 1. Although the clinical course is often relatively mild, inter-and intrafamilial phenotypic variations are observed. Asymptomatic mutation carriers, as well as patients showing severe muscular weakness and atrophy, have been reported. One diagnostic hallmark of the demyelinating CMT type 1 is a reduced nerve conduction velocity (NCV); patients with the axonal or CMT type 2 show almost normal NCVs [1] . Mutations in at least four different genes can cause CMT type 1: the peripheral myelin protein 22 gene (PMP22), the myelin protein zero gene (MPZ/P0), the connexin 32 (Cx32/ GJB1) gene, and the early growth response 2 gene (EGR2) [2] . The vast majority of patients carry a 1.4-Mb duplication in chromosome 17p11.2-12, including the PMP22 gene [3, 4] . Less frequently, mutations in P0 are observed as a cause of CMT type 1B disease (CMT1B) [Online Mendelian Inheritance in Man (OMIM), http:// www.ncbi.nlm.nih.gov/omim (MIM 118200)] [5] .
P0 is the major structural protein of peripheral myelin, an integral membrane glycoprotein (28 kilodaltons) that is expressed exclusively in the Schwann cells. It is composed of an extracellular domain (immunoglobulin related), a transmembrane domain, and a basic intracellular domain. It contributes to the compaction of the intraperiod and major dense line [6, 7] . The gene is located on chromosome 1q22-q23 and is composed of six coding exons. Both extracellular and intracellular domains are important for adhesion and myelination [8, 9] . Mutations in P0 may affect the ability to form homotetramers or to mediate homophilic adhesion, processes that are fundamental for the compaction of myelin sheaths in peripheral nerves [10] . Morphological studies of patients with CMT 1B indicate signs of demyelination, such as thinly myelinated nerve fibers, impaired Schwann cell proliferation, tomacula, and uncompacted myelin layers. In addition to the pathological changes of the myelin sheath, axonal degeneration may be observed [11] .
It is difficult to establish a correlation between genotype and phenotype of P0-related peripheral neuropathies [2] . Two severe, early onset forms of peripheral neuropathies, the Dejerine-Sottas syndrome and congenital hypomyelinating neuropathy, demonstrate the wide phenotypic variation of patients carrying P0 mutations, depending on the codon position and the nature of the substitution [12] . Additionally the Roussy-Levy syndrome could be associated with a specific mutation in the extracellular domain of P0 [13] .
Moreover, the phenotypic variability of P0 mutation carriers comprises axonally pronounced peripheral neuropathies (CMT2), which has been shown for a Thr124Met mutation [14, 15] . Carriers of this Thr124Met mutation also show Argyll Robertson-like pupils, and deafness and dysphagia frequently accompany the disease. Here we present CMT patients of a Costa Rican family who carry a previously undescribed Tyr145Ser mutation of the P0 gene in the heterozygous and homozygous state. The severity of the peripheral neuropathy corresponds to the genetic state of this particular P0 mutation.
Materials and methods
A Costa Rican family of four generations with six living CMT patients was investigated. DNA from the family members was obtained from peripheral blood, following standard methods.
All six coding P0 exons were amplified for the following individuals: III:1, III:2, III:3, III:4, III:5, III:6, III:7, IV:1, and IV:2, using primer sequences already published [16] . Sequencing was performed in both directions, using the same primers and BigDye Terminator version 3.0 (Applied Biosystems) with an ABI 3100 DNA Sequencer (Applied Biosystems), and analyzed with the Sequence Analyzer (Applied Biosystems) and Seqman II (DNAstar) software. For all these procedures, informed consent from the family members was obtained.
Family history was collected, in order to find a genealogical relationship between individuals III:4 and III:5, and to document the phenotype of the family ancestors. To evaluate this relationship experimentally, microsatellite markers close to P0 were investigated in the family members. Specific primers for repeats in loci D1S2705 and D1S2771 were used for polymerase chain reaction (PCR), and the products were analyzed with an ABI 3100 Sequencer and Genescan and Genotyper software (Applied Biosystems).
A physical examination was performed in subjects III:4, III:5, IV:1, and IV:2. Motor weakness and muscle wasting, sensory perception for light touch, pain, vibration, and joint position, deep tendon reflexes, and skeletal deformities were assessed. The cranial nerve status was also examined. Standard electrophysiological tests [17] were performed in the median, ulnar, peroneal, tibial, and sural nerves in all subjects. A sural nerve biopsy was taken from individual IV:1 and processed for light and electron microscopy according to standard techniques. The sural nerve was fixed with glutaraldehyde and embedded in epoxy resin. For light microscopy 1-m sections were stained with methylene blue. For electron microscopy, 80-nm ultrathin sections were stained with lead citrate and uranyl acetate. Morphometric parameters were analyzed by light (200 enlargement) and electron microscopy (between 1,600 and 16,700 enlargement).
Results
The hereditary peripheral neuropathy in family CR-CMT2 follows an autosomal dominant pattern of inheritance ( Fig. 1) . The family history of subjects III:4 and III:5, indicated that individuals I:1, II:1, II:4, and II:5 possibly also presented the disease.
No mutations were found in the P0 exons 1, 2 and 4-6 in any family member. In contrast, in the P0 exon 3 an A!C transversion (c.434A>C) was found, resulting in a novel missense mutation Tyr145Ser. Individuals III:1, III:4, III:5, and III:6 are heterozygous for this mutation, whereas individuals IV:1 and IV:2 (children of two heterozygous patients) are homozygous carriers (Fig. 2) . Healthy individuals of the family do not carry the mutation. This transversion has not been reported previously, either as a polymorphism or as a pathogenic mutation (Inherited Peripheral Neuropathies Mutation Database, http://molgen-www.uia.ac.be/cmtMutations/). In addition, 50 healthy non-related controls were screened who did not carry this Tyr145Ser mutation.
Although it was not possible to establish a genealogical relationship between the paternal and the maternal branches, analysis with polymorphic markers showed that in both branches the mutated allele is related to a 148-bp PCR product of marker D1S2705 and a 250-bp PCR product of marker D1S2771.
Upon clinical examination, individuals III:1, III:4, III:5, and III:6 had a mild peripheral neuropathy characterized by a late age of onset (after 51 years), whereas individuals IV:1 and IV:2 had an earlier age of onset (38 and 39 years, respectively) and a more-severe neuropathy.
The parents III:4 and III:5, heterozygous for the Tyr145Ser mutation, as well as their children IV:1 and IV:2, homozygous for the Tyr145Ser mutation, were studied in more detail. The father (patient III:4) did not report a serious impairment of his daily activities at 65 years of age. Disease duration ranged from 2 to 4 years in the siblings, and was 11 years in the mother (III:5); the father's (III:4) disease duration could not be defined exactly. All mutation carriers showed distal sensory deficits in a stocking-glove pattern for light touch and pin perception, which were more pronounced in the lower limbs. Vibration perception in the feet was severely impaired in all patients. Individuals III:5, IV:1, and IV:2 showed mild sensory ataxia. Motor weakness and wasting of distal muscles were present only in the children IV:1 and IV:2. Deep tendon reflexes of the lower limbs (ankle jerk, patellar and adductor deep tendon reflexes) were reduced or absent in the mother and children, whereas the father's patellar deep tendon reflex was still preserved. Pupillary abnormalities with mydriasis and no reaction to light were also only present in the siblings IV:1 and IV:2. The daughter IV:1 reported progressive deafness; she presented mild hypacusis of both ears. The electrophysiological studies revealed reduced or absent compound muscle action potentials and normal or reduced motor NCVs in the lower limbs. Sensory nerve action potentials of the sural nerve could be detected only in the daughter, with a reduced amplitude and a prolonged sensory NCV. Electromyographic studies of the anterior tibial muscle were compatible with either active or chronic denervation as a sign of axonal lesion. An increased number of polyphasic motor unit potentials (MUPs) and increased amplitudes of the MUPs were found. A pattern of reduced recruitment activity to full effort was also observed. The diagnosis was further confirmed by a sural nerve biopsy of the daughter.
Analysis of the semithin sections revealed a moderate decrease in myelinated nerve fiber density. Clusters of mainly four to six thinly myelinated nerve fibers were observed, showing regenerating axonal sprouts. Additionally, several thinly myelinated axons could be found, often surrounded by proliferating Schwann cells forming onion bulbs. The ultrastructural examination showed periand intra-axonal vacuoles as a sign of axonal degeneration. Clusters of unmyelinated axons in bands of Büngner indicated wallerian degeneration. Furthermore, signs of myelin degeneration, with decompacted lamellae of the myelin layers and abnormal myelin thickening forming loops and folds, were detected. These findings confirmed the electrophysiological findings of both axonal and myelin degeneration.
Discussion
We present a Costa Rican family with a novel Tyr145Ser MPZ mutation in both the homozygous and heterozygous Fig. 1 Pedigree of the Costa Rican family CR-CMT2 with autosomal dominant Charcot-Marie-Tooth disease. Phenotypes of members of the first and second generation are assumed according to testimonies of descendents. Individuals IV:1 (+) and IV:2 (+) are homozygous for a mutation in MPZ and presented a more-severe phenotype than the heterozygous members state. Two generations of one family were included in the study; both parents were heterozygous for this Thr145Ser mutation, and both siblings were homozygous. This particular mutation was not observed in healthy family members.
Although a genealogical relationship between the paternal and maternal branches has not been found, genotype analysis of polymorphic markers showed that in both branches the same haplotype is related to the P0 mutation. This suggests that the mutation in all affected individuals presented here has a common origin, and a genealogical connection among the ancestors of individuals III:4 and III:5 can be predicted.
In this family, siblings and parents differed significantly in their clinical findings. The homozygous siblings showed an earlier age of onset (38, 39 years) compared with the parents (mother 51 years, father unclear) anddespite a much-shorter disease duration-had morepronounced clinical deficits. Only the homozygous Tyr145Ser carriers showed distal motor weakness and muscle wasting, as well as distinct features such as pupillary abnormalities and progressive bilateral deafness of the daughter. Common clinical findings were sensory deficits, including sensory ataxia, and deep tendon reflex abnormalities. The electrophysiological studies revealed signs of axonal degeneration and demyelination in both heterozygous and homozygous subjects. Electrophysiological abnormalities were also more pronounced in the siblings. A sural nerve biopsy of the homozygous daughter showed axonal degeneration and regeneration, including axonal sprouts, and signs of demyelination, such as decompacted myelin, thinly myelinated and unmyelinated axons (Fig. 3) .
There are few reports of families that are both homozygous and heterozygous for mutations in myelin genes. Ikegami et al. [18] described a family with a deletion of codon 64 (Phe64del) of the P0 gene. The parents were heterozygous and the siblings homozygous for this mutation. The parents presented subclinical CMT1B and moderately slow NCVs, whereas the children presented a Dejerine Sottas syndrome. Parman et al. [19] reported a family with an Arg157Trp mutation in PMP22; the parents were clinically and electrophysiologically unaffected, and the children presented Dejerine-Sottas disease.
Warner et al. [12] found a frameshift mutation in P0 (c.306delA, Val102fs74) which, in parallel to our study, caused mildly affected heterozygous carriers (parents) and severely diseased homozygous carriers (children). In contrast to our family, the age of onset of sensory and motor deficits of the heterozygous parents was earlier; the homozygous siblings showed delayed acquisition of motor milestones, severe motor weakness and wasting, muscle hypotonia, bilateral pes cavus, areflexia, and sensory deficits. Electrophysiological studies in the parents revealed mildly delayed motor and sensory NCVs. Motor and sensory nerve action potentials could no longer be recorded in the children. In contrast to our morphological findings, no axonal degeneration was found on sural nerve biopsy taken from one of the children, but massive demyelination, thinning of the nerve fibers, and onion bulb formation was reported.
Uncharacteristic clinical findings among CMT patients, such as pupillary abnormalities and deafness, have been associated with distinct P0 mutations [14, 20] . De Jonghe et al. [14] reported seven families with an age of onset in the 4th and 5th decade, a rapidly progressive muscle weakness, and severe sensory abnormalities. Many patients initially complained of shooting pain in the legs. Similar to our findings in the homozygous siblings, morphological studies showed axonal degeneration, small onion bulb formation, thin-to-normal myelin sheaths, and occasionally focal myelin thickenings with redundant loop formation.
In previous studies P0 mutations have been shown to cause a variety of neuropathy phenotypes, including CMT1B [5, 21, 22] , Dejerine-Sottas disease [5, 12, 23] , and congenital hypomyelination [12] . As in this study, not only demyelination, but also axonal degeneration, was associated with P0 mutations [22, 24, 25] . It has been suggested that axonal degeneration is most likely secondary to myelin dysfunction, possibly due to impaired axoglial interactions [22] . In agreement with these observations in humans, experimental studies in P0-deficient mice showed axonal degeneration [26, 27] . In contrast to homozygous P0 -/-deficient mice, heterozygous P0 +/-mutants are less severely affected; in particular they do not have any signs of axonal degeneration [28, 29] .
On electron microscopy, we observed abnormal myelin formation and decompaction of myelin sheaths as previously described [20, 21] . These have been proposed to be due to malfunction of P0 and its adhesive properties. The extracellular domain of P0, a large immunoglubulinlike domain that carries a HNK-1 carbohydrate epitope, provides the adhesion properties of P0 and participates in the formation and compaction of the intra-and interperiod line of myelin [8, 30, 31] . The Tyr145Ser mutation is located in this extracellular domain, as are the vast majority of the reported mutations in P0 that cause a peripheral neuropathy. A reduced adhesion capability could be the reason for this particular CMT disease. Nevertheless, a loss of adhesion is not exclusive for mutations in the extracelluar domain, since it has been demonstrated that mutations in the cytoplasmic domain also destroy the adhesive function of P0 and cause CMT1B [32, 33] . However, this mutation has not yet been included in adhesion assays, hence a disease mechanism via impairment of adhesion remains hypothetical.
Furthermore, these features are not unique for P0 mutations, since similar observations have been made for CMT-related mutations in the peripheral myelin protein PMP 22 gene and in neuropathies associated with gammopathies [34] .
Recently, a 15-year-old boy heterozygous for a Val146Phe P0 mutation was reported, who showed much more-severe symptoms compared with the Tyr145Ser carriers [35] . Although the Val146Phe mutation occurred in the neighboring amino acid, the patient presented at an early age with progressive gait disturbances, foot deformity, and a median NCV of 5.0 m/s. This again demonstrates that the phenotypic variability of patients with hereditary neuropathies caused by P0 mutations depends on the position and nature of the respective amino acid exchange. Both tyrosine and serine are neutral amino acids, hence this mutation does not change the charge but may create some steric problems for the function of P0 as an adhesion molecule. The phenotypic influence of this amino acid exchange seems to be more moderate in heterozygous carriers, since motor deficits were only found in the homozygous subjects, suggesting a loss of function resulting from this particular mutation. However, the homozygous exchange causes not only a typical peripheral neuropathy but also pupillary abnormalities. P0 has exclusively been found in the peripheral nervous system [8] and the mechanism of impaired pupillary reaction in some patients with P0 mutations remains unclear.
A mutation in the extracellular domain of P0 (Cys21) has been proven to have a dominant-negative effect on adhesion of wild type P0, because cells that co-express wild type and the mutant allele lose their adhesive properties [36] . Therefore, it is possible to hypothesize that the Tyr145Ser P0 mutation would cause a mild dominant form of CMT, due to a not very aggressive dominant-negative effect in heterozygous patients. However, in the case of homozygosity, the fundamental role of P0 in adhesion and compaction would be played only by subnormal proteins, resulting in a more-severe neuropathy.
